Interestingly, our findings showing increases in both p-GSK-3β and GSK-3β-Ser9 are similar to that seen reccently in Alzheimer's disease, where GSK3β was found to be phosphorylated to a similar extent at both the regulatory sites, Ser9 and Tyr216 [47]. This evidence concerns the gene GSK3B and Alzheimer disease.